TATVA CHINTAN Q2 FY27 ;, NET PROFIT UP 117% AT ₹21.50 CR (YOY), UP 34% (QOQ)

REVENUE UP 76% AT ₹217.30 CR (YOY), UP 30% (QOQ) EBITDA UP 81% AT ₹40 CR (YOY), UP 24% (QOQ) MARGINS AT 18.5% VS 18.0% (YOY), 19.4% (QOQ)

TATVA CHIN PHARM CHEM LTD